AVIMOTIN

EUIPO EUIPO 2008 Registration expired

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The Union trademark AVIMOTIN was filed as Word mark on 11/03/2008 at the European Union Intellectual Property Office.
It was registered as a trademark on 06/10/2009. The current status of the mark is "Registration expired".

Trademark Details Last update: September 4, 2019

Trademark form Word mark
File reference 007360043
Application date November 3, 2008
Publication date February 2, 2009
Entry date June 10, 2009
Expiration date November 3, 2018

Trademark owner

Lochhamer Str. 11
82152 Planegg, Martinsried
DE

Trademark representatives

Josephspitalstr. 15 80331 München DE

goods and services

5 Pharmaceutical and veterinary preparations for the prevention, treatment and/or diagnosis of diseases, in particular medicines, vaccines, serums and/or test kits for the prevention, treatment and/or diagnosis of tumour precursors, benign and malignant tumours, in particular warts, genital warts, neuronal tumours, glioma, astrocytoma, colon carcinoma, ovarian carcinoma, cervical cancer, prostate carcinoma, basal cell carcinoma, squamous cell carcinoma, melanoma, Kaposi's sarcoma, breast cancer, head and neck carcinomas, hepatocellular carcinoma, bronchial carcinoma, pancreatic tumours and/or renal tumours, autoimmune disorders, in particular rheumatoid arthritis, polyarthritis, Crohn's disease, lupus erythematosus and/or multiple sclerosis, neurodegenerative disorders, in particular Alzheimer's disease, Huntington's disease, multiple sclerosis, Parkinson's disease, schizophrenia, transmissible spongiform encephalopathy, bovine spongiform encephalopathy and/or Creutzfeldt-Jakob disease, rheumatic disorders, in particular rheumatoid arthritis, polychondritis, Bechterew's disease, fibromyalgia and/or lupus erythematodes, allergic diseases, in particular allergies, allergic rhinitis, hay fever, asthma, atopic eczema and/or insect sting allergies, cardiovascular disorders, in particular hyperlipidaemia, coronary artery disorders, cardiac insufficiency, high blood pressure and/or obesity, skin diseases, in particular warts, genital warts, Bowen's disease, actinic keratosis, seborrhoeic keratosis, psoriasis, dermatitis, eczema, acne, rosacea and/or herpes, infectious diseases, in particular viral infections, bacterial infections, parasitic infections and/or fungal infections, and/or ophthalmic disorders, in particular age-dependent macular degeneration, glaucoma and/or retinoblastoma, in particular low-molecular active substances, liposomes, aptamers, nucleic acids, peptides, proteins, protein conjugates, antibodies, T-cell proteins, enzymes and enzyme preparations, hormones, hormone analogues, attenuated viruses, virus-type particles and/or plant extracts; in particular for oral, topical, intravenous and/or subcutaneous administration

Trademark history

Date Document number Area Entry
September 3, 2019 Extension, Trade mark expired
March 5, 2015 Change Representative, Published
May 11, 2010 Change Representative, Published
July 6, 2009 Registration, Published

ID: 11007360043